| 000 | 01515 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517121305.0 | ||
| 264 | 0 | _c20180226 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.12513 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Kai | |
| 245 | 0 | 0 |
_aPhosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. _h[electronic resource] |
| 260 |
_bOncotarget _cNov 2016 |
||
| 300 |
_a75968-75980 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnaplastic Lymphoma Kinase |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aComputational Biology _xmethods |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aNeuroblastoma _xmetabolism |
| 650 | 0 | 4 |
_aPhosphoproteins _xmetabolism |
| 650 | 0 | 4 | _aProtein Kinase Inhibitors |
| 650 | 0 | 4 | _aProteome |
| 650 | 0 | 4 |
_aProteomics _xmethods |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aras Proteins _xmetabolism |
| 700 | 1 | _aLv, Fan | |
| 700 | 1 | _aXu, Guofeng | |
| 700 | 1 | _aZhang, Min | |
| 700 | 1 | _aWu, Yeming | |
| 700 | 1 | _aWu, Zhixiang | |
| 773 | 0 |
_tOncotarget _gvol. 7 _gno. 46 _gp. 75968-75980 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.12513 _zAvailable from publisher's website |
| 999 |
_c26508575 _d26508575 |
||